12 August 2026
Annotate
In your population, that variant may be ordinary
Rarity flips depending on which population you measure it against. Decide in advance where your frequencies come from, and "rare, therefore a weakness" stops being a reading you can make by accident.
Somewhere in your reading you hit a line saying that only a few per cent of people carry this form. It feels like you have turned up something singular.
Stop there for a moment. A few per cent of whom?
Rarity flips with the baseline
An allele frequency is a count taken within a population. A form can sit at twenty per cent in Europeans and eighty per cent in East Asians. That is ordinary, not exotic.
Which means one genotype reads as a rare variant against one baseline and as what most people carry against another. Neither number is wrong. They have different denominators.
For reading your own data, the number that carries meaning is the one from the population you belong to.
Defaults usually come from European cohorts
Explanatory articles and tool defaults are frequently built on European-ancestry cohorts. That is where the research has historically concentrated; nobody arranged it against you.
Apply those defaults unaltered, though, and forms that are unremarkable in East Asia line up on your page as rare variants.
The same holds for numbers coming out of association studies — which allele was flagged, how large the association was, how it travels with neighbouring variants. These do not carry across populations unchanged. The imbalance has been pointed out repeatedly, and the hazard of importing such numbers without correcting for the skew is one the field itself has warned about (Martin et al., 2019).
Decide where frequencies come from, in advance
Stop using whichever number search happens to surface. Fix the sources, and fix the order you consult them in.
| What you want | Where to get it |
|---|---|
| Japanese population frequency | jMorp (Tohoku Medical Megabank Organization) |
| Japanese population frequency, aggregated | TogoVar |
| Global figures, broken down by ancestry group | gnomAD |
| The basis for how populations are grouped | 1000 Genomes / IGSR |
The order runs Japanese population → East Asian → global. Come at it from the other end and the first number you saw colours everything after it.
The jMorp panel grows with each update, and gnomAD versions differ in which samples were aggregated. So, once again: note which version, and which number, you actually looked at.
With a database that aggregates the world, read the breakdown rather than the overall figure. The global average describes no population in particular.
Where you sit within the population
When you look at a frequency for one position, keeping three cases apart makes the rest straightforward.
- Homozygous for the population’s major form — the standard shape in that population
- Heterozygous — carrying the different form on one side
- Homozygous for the minority form — sitting out towards the edge within that population
This is not a good-or-bad distinction. It is a statement of position within a population — nothing more. Not loading it with weight is, in itself, most of the accuracy.
What frequency alone will not settle
Position by frequency is not always sufficient.
Where the direction of function is established in the literature. A form can be common in a population and still have a documented functional consequence. “Common, therefore functionally irrelevant” does not follow.
Where public databases carry annotations on drug response or clinical significance. However common the form, the annotation is what you read.
Frequency is a measure of rarity, not a measure of function. Let the two merge and you can no longer speak clearly about either.
Rarity is not a verdict
The part that matters most, last.
Being rare is not being worse off. “You carry a form that very few people have” can be an accurate statement and still turn into something else the instant weight is laid on it. Rarity makes an easy instrument of fear.
Building the habit of looking up frequencies is partly about precision. More than that, it is the footing that stops rarity from being used to frighten people — and when you are reading your own data, the first person it protects is you.
If something about your health is on your mind, please take it to a medical professional, separately from any of this.
References
- jMorp — Tohoku Medical Megabank Organization
- TogoVar — Database Center for Life Science
- gnomAD — Broad Institute
- IGSR / 1000 Genomes Project
- 1000 Genomes Project Consortium (2015) A global reference for human genetic variation — Nature
- Martin et al. (2019) Clinical use of current polygenic risk scores may exacerbate health disparities — Nature Genetics